New diabetes clinical trial: A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

Published on: 2026-04-20T04:00:00Z
Conditions: Diabetes Mellitus; Weight Loss
Interventions: Drug: HRS9531 Injection
Sponsors: Fujian Shengdi Pharmaceutical Co., Ltd.
Not yet recruiting
https://ift.tt/pUOi3Sc